These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 18034208)

  • 1. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Gales AC; Menezes LC; Silbert S; Sader HS
    J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.
    Khosravi Y; Tee Tay S; Vadivelu J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):294-6. PubMed ID: 20462725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
    Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
    J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa.
    Manoharan A; Chatterjee S; Mathai D;
    Indian J Med Microbiol; 2010; 28(3):241-4. PubMed ID: 20644314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
    Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
    Lee K; Ha GY; Shin BM; Kim JJ; Kang JO; Jang SJ; Yong D; Chong Y;
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):51-8. PubMed ID: 15380278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates].
    Mereuţă AI; Tuchiluş C; Bădescu AC; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1208-13. PubMed ID: 22276471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
    J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic and genotypic characterization of imipenem-resistant Pseudomonas aeruginosa isolated in a Buenos Aires hospital].
    Cejas D; Almuzara M; Santella G; Tuduri A; Palombarani S; Figueroa S; Gutkind G; Radice M
    Rev Argent Microbiol; 2008; 40(4):238-45. PubMed ID: 19213249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals.
    Glupczynski Y; Bogaerts P; Deplano A; Berhin C; Huang TD; Van Eldere J; Rodriguez-Villalobos H
    J Antimicrob Chemother; 2010 May; 65(5):866-71. PubMed ID: 20200037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of metallo-beta-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumannii by E-test, disk synergy and PCR.
    Aktaş Z; Kayacan CB
    Scand J Infect Dis; 2008; 40(4):320-5. PubMed ID: 17934980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characterization of metallo-beta-lactamases in clinical isolates of pseudomonas aeruginosa.
    Luzzaro F; Endimiani A; Docquier JD; Mugnaioli C; Bonsignori M; Amicosante G; Rossolini GM; Toniolo A
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):131-5. PubMed ID: 14972383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of metallo-β-lactamase IMP-14 and VIM-2 in Pseudomonas aeruginosa clinical isolates from a tertiary-level hospital in Thailand.
    Piyakul C; Tiyawisutsri R; Boonbumrung K
    Epidemiol Infect; 2012 Mar; 140(3):539-41. PubMed ID: 21733273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.